Literature DB >> 18810764

Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Cristina Saro Gismera1, Beatriz Sicilia Aladrén.   

Abstract

Inflammatory bowel diseases (IBD) are a heterogeneous group of diseases, not always easy to diagnose, even more difficult to classify, and diagnostic criteria are not always uniform. Well done population-based studies are not abundant, and so comparisons among different geographical areas or populations are not always very reliable. In this article, we have reviewed epidemiological studies available on the world's population while making a critical review of published data.

Entities:  

Mesh:

Year:  2008        PMID: 18810764      PMCID: PMC2746333          DOI: 10.3748/wjg.14.5491

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  92 in total

1.  Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998.

Authors:  R Salupere
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis.

Authors:  J F Blanchard; C N Bernstein; A Wajda; P Rawsthorne
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

3.  Crohn's disease incidence in Cardiff from 1930: an update for 1991-1995.

Authors:  T R Yapp; R Stenson; G A Thomas; B W Lawrie; G T Williams; A B Hawthorne
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-08       Impact factor: 2.566

4.  Incidence and prevalence of ulcerative colitis in Punjab, North India.

Authors:  A Sood; V Midha; N Sood; A S Bhatia; G Avasthi
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

5.  Continuing low incidence of Crohn's disease in Northwest Greece.

Authors:  E V Tsianos; K H Katsanos; D Christodoulou; I Dimoliatis; A Kogevinas; R F Logan
Journal:  Dig Liver Dis       Date:  2003-02       Impact factor: 4.088

Review 6.  The effect of infections on susceptibility to autoimmune and allergic diseases.

Authors:  Jean-Francois Bach
Journal:  N Engl J Med       Date:  2002-09-19       Impact factor: 91.245

7.  [Incidence of inflammatory bowel disease in Aragon: outcome of a prospective population-based study].

Authors:  C Lopez Miguel; B Sicilia; E Sierra; J Lopez Zaborras; F Arribas; F Gomollon
Journal:  Gastroenterol Hepatol       Date:  1999 Aug-Sep       Impact factor: 2.102

8.  Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997.

Authors:  S K Yang; W S Hong; Y I Min; H Y Kim; J Y Yoo; P L Rhee; J C Rhee; D K Chang; I S Song; S A Jung; E B Park; H M Yoo; D K Lee; Y K Kim
Journal:  J Gastroenterol Hepatol       Date:  2000-09       Impact factor: 4.029

9.  [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].

Authors:  C Saro Gismera; M Lacort Fernández; G Argüelles Fernández; J Antón Magarzo; R García López; C A Navascues; A Suárez González; G Díaz Alvarez; A González Bernal; A Palacios Galán; A Altadill Arregui; F Vizoso
Journal:  Gastroenterol Hepatol       Date:  2000 Aug-Sep       Impact factor: 2.102

10.  Inflammatory bowel disease: epidemiology and management in an English general practice population.

Authors:  G P Rubin; A P Hungin; P J Kelly; J Ling
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

View more
  33 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

2.  T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitis.

Authors:  J Zimmermann; A A Kühl; M Weber; J R Grün; J Löffler; C Haftmann; R Riedel; P Maschmeyer; K Lehmann; K Westendorf; M-F Mashreghi; M Löhning; M Mack; A Radbruch; H D Chang
Journal:  Mucosal Immunol       Date:  2016-02-17       Impact factor: 7.313

Review 3.  New molecular insights into inflammatory bowel disease-induced diarrhea.

Authors:  Yueming Tang; Christopher B Forsyth; Ali Keshavarzian
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-10       Impact factor: 3.869

4.  Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.

Authors:  Sandeep A Walujkar; Shreyas V Kumbhare; Nachiket P Marathe; Dhrati V Patangia; Parimal S Lawate; Renu S Bharadwaj; Yogesh S Shouche
Journal:  World J Microbiol Biotechnol       Date:  2018-05-23       Impact factor: 3.312

Review 5.  Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.

Authors:  Shapur Ikhtaire; Mohammad Sharif Shajib; Walter Reinisch; Waliul Islam Khan
Journal:  J Gastroenterol       Date:  2016-02-20       Impact factor: 7.527

6.  Simulated gastrointestinal digests of corn protein hydrolysate alleviate inflammation in caco-2 cells and a mouse model of colitis.

Authors:  Qiufang Liang; Xiaofeng Ren; Meram Chalamaiah; Haile Ma
Journal:  J Food Sci Technol       Date:  2020-01-29       Impact factor: 2.701

7.  Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value.

Authors:  Mariano A Ostuni; Leeyah Issop; Gabriel Péranzi; Francine Walker; Magali Fasseu; Carole Elbim; Vassilios Papadopoulos; Jean-Jacques Lacapere
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

8.  Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis.

Authors:  Nobin Babu Kalappurayil; Jino Thomas; Baburajan Mankuni; Varghese Thomas
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.

Authors:  K Kamikozuru; K Fukunaga; S Hirota; N Hida; Y Ohda; K Yoshida; Y Yokoyama; K Tozawa; K Kawa; M Iimuro; K Nagase; A R Saniabadi; S Nakamura; H Miwa; T Matsumoto
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

10.  Adenocarcinoma of the small bowel in a patient with occlusive Crohn's disease.

Authors:  Lior Drukker; Yair Edden; Petachia Reissman
Journal:  World J Gastrointest Oncol       Date:  2012-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.